Peptidoglycan hydrolase fusions maintain their parental specificities
about
A chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening methodRecombinant expression of two bacteriophage proteins that lyse clostridium perfringens and share identical sequences in the C-terminal cell wall binding domain of the molecules but are dissimilar in their N-terminal active domains'Artilysation' of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci.Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus.Expression of a Clostridium perfringens genome-encoded putative N-acetylmuramoyl-L-alanine amidase as a potential antimicrobial to control the bacterium.Staphylococcus haemolyticus prophage ΦSH2 endolysin relies on cysteine, histidine-dependent amidohydrolases/peptidases activity for lysis 'from without'Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88.EnzyBase: a novel database for enzybiotic studies.Bacteriophage endolysins as novel antimicrobials.Engineered bacteriophage lysins as novel anti-infectivesPotential of the virion-associated peptidoglycan hydrolase HydH5 and its derivative fusion proteins in milk biopreservation.Endopeptidase and glycosidase activities of the bacteriophage B30 lysinEvolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection.Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent.A Thermophilic Phage Endolysin Fusion to a Clostridium perfringens-Specific Cell Wall Binding Domain Creates an Anti-Clostridium Antimicrobial with Improved Thermostability.Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands.Discovery of novel S. aureus autolysins and molecular engineering to enhance bacteriolytic activity.Synergistic streptococcal phage λSA2 and B30 endolysins kill streptococci in cow milk and in a mouse model of mastitis.LambdaSa1 and LambdaSa2 prophage lysins of Streptococcus agalactiaeThe lactococcal phages Tuc2009 and TP901-1 incorporate two alternate forms of their tail fiber into their virions for infection specializationMolecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysinStaphylococcal phage 2638A endolysin is lytic for Staphylococcus aureus and harbors an inter-lytic-domain secondary translational start site.PL3 Amidase, a Tailor-made Lysin Constructed by Domain Shuffling with Potent Killing Activity against Pneumococci and Related SpeciesBacteriophage and their lysins for elimination of infectious bacteria.Novel chimeric lysin with high-level antimicrobial activity against methicillin-resistant Staphylococcus aureus in vitro and in vivoMolecular dissection of phage endolysin: an interdomain interaction confers host specificity in Lysin A of Mycobacterium phage D29.Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection processGenetically modified bacteriophages in applied microbiology.Role of SH3b binding domain in a natural deletion mutant of Kayvirus endolysin LysF1 with a broad range of lytic activity.A novel chimeric phage lysin with high in vitro and in vivo bactericidal activity against Streptococcus pneumoniae.EC300: a phage-based, bacteriolysin-like protein with enhanced antibacterial activity against Enterococcus faecalis.The cell lysis activity of the Streptococcus agalactiae bacteriophage B30 endolysin relies on the cysteine, histidine-dependent amidohydrolase/peptidase domain.Exploiting what phage have evolved to control gram-positive pathogensGenomic sequence of bacteriophage ATCC 8074-B1 and activity of its endolysin and engineered variants against Clostridium sporogenes.The tape measure protein of the Staphylococcus aureus bacteriophage vB_SauS-phiIPLA35 has an active muramidase domain.Chimeric Ply187 endolysin kills Staphylococcus aureus more effectively than the parental enzyme.Engineering of Phage-Derived Lytic Enzymes: Improving Their Potential as Antimicrobials.Potential for Bacteriophage Endolysins to Supplement or Replace Antibiotics in Food Production and Clinical Care.Characterization of the activity of the spore cortex lytic enzyme CwlJ1.Recombinant Expression of a Putative Amidase Cloned from the Genome of Listeria monocytogenes that Lyses the Bacterium and its Monolayer in Conjunction with a Protease.
P2860
Q27304933-8D53DE09-DAE8-41A7-ACE7-1F557DAF3767Q28391327-0BCC2C5C-4E36-47C0-A460-773D47579D4BQ30825736-5453CE10-8082-4D6D-ABA6-55BB3E900EADQ33525230-6A39406F-7141-401C-B538-35B867AD75A6Q33594623-4BF323F3-6D1F-4849-9EE5-3009AD7BB2F9Q33775374-A28C8D91-743D-483A-9644-5CE635EFEF01Q33935353-AFE6CC44-D250-42FB-852A-E9179DE149FBQ34226868-972E27CB-7A0F-4F9F-BBA4-4A5C07142C70Q34303439-BE7457E2-0B26-46C9-9828-625C7E87396BQ34349552-D8C18214-9C2D-4D61-88AF-1B5579EDCC3FQ34566563-F3DBB634-3E1A-407A-AB80-71892317B6F7Q35091838-2CE5AC76-E11F-4103-970C-697DE4FE74DBQ35432724-6864C972-2194-49E7-9959-62E5236707F8Q35653429-998D3E0C-50E3-4DE5-8E0D-8DB4AD6467BBQ35808669-AB9A3D9F-0975-41BA-A69A-B13C423D9779Q35827070-338C2F44-4855-4335-A35A-5D2F55C8E74DQ35842148-6269B189-D8C2-4CFF-82F6-78979536ED20Q36070204-2B74ABD2-F9EA-43D8-9B9E-9EC82F0D28C7Q36313687-CF2B02CD-A8C5-487F-8C80-9DFA9216CB70Q36635974-FE6AF945-6D2B-4F1D-AFB7-D63FA0721854Q36933726-0D483DA8-C93B-411B-B1FB-911BF8293645Q37062915-4976EE26-A4F5-4CB4-AEA1-4D4B3715E15AQ37131742-4DF94553-3CF0-46EB-8F65-3513F88BDDAFQ37470848-C8D03638-D7FB-46BD-B79D-8B53436D49F3Q37544464-D7EEC5E3-C0DC-4C93-B23F-C29A210A78A8Q37727646-EB44E313-9DEC-4B13-B917-8AA3E4A6E4C1Q37737552-94C99ACA-782E-4573-B469-20EC78B4DB2BQ38870317-5385313E-6E7A-4305-B6F0-E226F02426CCQ40065482-284261F6-AABE-471D-9F8D-DA1188CED47DQ41454348-F307CABB-42F1-48A7-B950-3CDE22FDD528Q41457130-D2A74A1A-FB6F-4D4E-AF42-F972BD8A4A8BQ41487168-453128AE-1163-4692-96E9-7920F2182C09Q42072037-5FF727FE-143A-4F2C-B1AD-B1EF1F2B4773Q42151193-156ABB57-B7BF-465A-82EE-A1BCEA4D6C1EQ42271272-8EDC7752-C7E7-4371-BE97-5D520A5490BEQ43117931-E6A60742-26E0-4214-B981-650FFFB31B09Q52642775-F1FEE392-D9DA-4B9A-9E92-8EEB9A9FE28CQ52679093-42D82491-8678-402E-AA51-D86825BB8078Q53315467-E6437A4C-E87D-4AB4-B850-C5FF3D9A9112Q54341780-8357B272-FA0E-44DB-B82B-C25B1A8B5D3C
P2860
Peptidoglycan hydrolase fusions maintain their parental specificities
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Peptidoglycan hydrolase fusions maintain their parental specificities
@ast
Peptidoglycan hydrolase fusions maintain their parental specificities
@en
type
label
Peptidoglycan hydrolase fusions maintain their parental specificities
@ast
Peptidoglycan hydrolase fusions maintain their parental specificities
@en
prefLabel
Peptidoglycan hydrolase fusions maintain their parental specificities
@ast
Peptidoglycan hydrolase fusions maintain their parental specificities
@en
P2093
P2860
P1476
Peptidoglycan hydrolase fusions maintain their parental specificities
@en
P2093
David G Pritchard
David M Donovan
Shengli Dong
Wes Garrett
P2860
P304
P356
10.1128/AEM.72.4.2988-2996.2006
P407
P577
2006-04-01T00:00:00Z